Evaluation of patient-specific cell free DNA assays for monitoring of minimal residual disease in solid tumors
View ORCID ProfileDadasaheb Akolkar, Darshana Patil, Sneha Puranik, Swapnil Puranik, Pratiksha Sunil Nandre, Karishma Raosaheb Sabale, Sachin Apurwa, Harshal Bodke, Navin Shrivastava, Vineet Datta, Stefan Schuster, Jinumary John, Ajay Srinivasan, Rajan Datar
doi: https://doi.org/10.1101/2022.04.07.22273446
Dadasaheb Akolkar
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Darshana Patil
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Sneha Puranik
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Swapnil Puranik
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Pratiksha Sunil Nandre
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Karishma Raosaheb Sabale
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Sachin Apurwa
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Harshal Bodke
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Navin Shrivastava
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Vineet Datta
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Stefan Schuster
2Datar Cancer Genetics Europe GmbH, Eckersdorf, Bavaria, Germany
Jinumary John
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Ajay Srinivasan
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Rajan Datar
1Department of Research and Innovation, Datar Cancer Genetics, Nasik, Maharashtra, India
Article usage
Posted April 12, 2022.
Evaluation of patient-specific cell free DNA assays for monitoring of minimal residual disease in solid tumors
Dadasaheb Akolkar, Darshana Patil, Sneha Puranik, Swapnil Puranik, Pratiksha Sunil Nandre, Karishma Raosaheb Sabale, Sachin Apurwa, Harshal Bodke, Navin Shrivastava, Vineet Datta, Stefan Schuster, Jinumary John, Ajay Srinivasan, Rajan Datar
medRxiv 2022.04.07.22273446; doi: https://doi.org/10.1101/2022.04.07.22273446
Evaluation of patient-specific cell free DNA assays for monitoring of minimal residual disease in solid tumors
Dadasaheb Akolkar, Darshana Patil, Sneha Puranik, Swapnil Puranik, Pratiksha Sunil Nandre, Karishma Raosaheb Sabale, Sachin Apurwa, Harshal Bodke, Navin Shrivastava, Vineet Datta, Stefan Schuster, Jinumary John, Ajay Srinivasan, Rajan Datar
medRxiv 2022.04.07.22273446; doi: https://doi.org/10.1101/2022.04.07.22273446
Subject Area
Subject Areas
- Addiction Medicine (382)
- Allergy and Immunology (699)
- Anesthesia (190)
- Cardiovascular Medicine (2837)
- Dermatology (243)
- Emergency Medicine (427)
- Epidemiology (12543)
- Forensic Medicine (10)
- Gastroenterology (801)
- Genetic and Genomic Medicine (4418)
- Geriatric Medicine (401)
- Health Economics (712)
- Health Informatics (2844)
- Health Policy (1046)
- Hematology (373)
- HIV/AIDS (893)
- Medical Education (413)
- Medical Ethics (114)
- Nephrology (461)
- Neurology (4173)
- Nursing (220)
- Nutrition (615)
- Oncology (2199)
- Ophthalmology (623)
- Orthopedics (254)
- Otolaryngology (317)
- Pain Medicine (266)
- Palliative Medicine (81)
- Pathology (485)
- Pediatrics (1171)
- Primary Care Research (482)
- Public and Global Health (6764)
- Radiology and Imaging (1487)
- Respiratory Medicine (897)
- Rheumatology (430)
- Sports Medicine (368)
- Surgery (472)
- Toxicology (57)
- Transplantation (200)
- Urology (173)